These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973 [TBL] [Abstract][Full Text] [Related]
44. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6. Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506 [TBL] [Abstract][Full Text] [Related]
45. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies. Wang YT; Su ZY; Liao JM; Chen CL Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354 [TBL] [Abstract][Full Text] [Related]
46. Estimation of variance distribution in three-dimensional reconstruction. II. Applications. Liu W; Boisset N; Frank J J Opt Soc Am A Opt Image Sci Vis; 1995 Dec; 12(12):2628-35. PubMed ID: 7500222 [TBL] [Abstract][Full Text] [Related]
47. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Lerner RA Nature; 1982 Oct; 299(5884):593-6. PubMed ID: 6181415 [TBL] [Abstract][Full Text] [Related]
48. Capturing transient antibody conformations with DNA origami epitopes. Zhang P; Liu X; Liu P; Wang F; Ariyama H; Ando T; Lin J; Wang L; Hu J; Li B; Fan C Nat Commun; 2020 Jun; 11(1):3114. PubMed ID: 32561744 [TBL] [Abstract][Full Text] [Related]
50. Determination of the number of Fab1 pieces which react with high molecular weight antigens. 1982. Polson A; van der Merwe KJ Prep Biochem; 1993; 23(1-2):93-107. PubMed ID: 8367409 [No Abstract] [Full Text] [Related]
51. [Contribution to the etiology and epidemiology of acute virus and mycoplasmatic infection. I. Laboratory findings]. Syrůcek L; Brůcková M; Fedová D; Kunzová L; Pecenková I; Strnad F; Strízová V; Stumpa A; Tůmová B; Vojtĕchovský K; Wágnerová E Cesk Epidemiol Mikrobiol Imunol; 1974 Aug; 23(4-5):218-26. PubMed ID: 4373175 [No Abstract] [Full Text] [Related]
52. Closer to a cure for the common cold? McIntosh K JAMA; 1999 May; 281(19):1844-5. PubMed ID: 10340373 [No Abstract] [Full Text] [Related]
53. Structural basis for antigen-antibody recognition. Huber R Science; 1986 Aug; 233(4765):702-3. PubMed ID: 2426777 [No Abstract] [Full Text] [Related]
54. Structural studies on antibody-virus complexes. Smith TJ Adv Protein Chem; 2003; 64():409-53. PubMed ID: 13677055 [No Abstract] [Full Text] [Related]
56. Trends in nano-platforms for the treatment of viral infectious diseases. Canlas KKV; Hong J; Chae J; Seo HW; Kang SH; Choi J; Park H Korean J Chem Eng; 2023; 40(4):706-713. PubMed ID: 37025620 [TBL] [Abstract][Full Text] [Related]